HOME >> MEDICINE >> NEWS
Cholesterol treatment, including statins, may slow Alzheimer's disease progression

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease, concludes a study in the Journal of Neurology Neurosurgery and Psychiatry.

The research team assessed the degree of brain function loss caused by Alzheimer's disease in 342 patients attending a memory clinic. They then monitored the progress of the disease for almost three years. The average age of the patients was 73. Most were women.

In all, 129 patients had abnormal cholesterol levels, almost half of whom were being treated exclusively with statins. Of the remainder, 105 had abnormal untreated cholesterol , and 108 had normal cholesterol levels. Drug treatment included fibrates or statins, or a mixture of both.

During the three years, all the patients deteriorated, but the disease progressed significantly more slowly in the patients given cholesterol lowering drugs. Progression of the disease was rated at 1.5 points a year in those given the drugs, 2.4 in those whose cholesterol was not treated, and 2.6 in those with normal cholesterol levels.

The risk factor profile for Alzheimer's disease, including high blood pressure and diabetes, scarcely differed between the two groups with abnormal cholesterol levels.

The authors conclude that cholesterol lowering drugs may effectively slow progression of Alzheimer's disease, but suggest that a large trial will be needed to confirm their findings.

An accompanying editorial argues that it is still too early to definitively conclude that cholesterol lowering treatment is a valid option for patients with Alzheimer's disease.

The editorial also points out that the research was not able to isolate the potential advantages of the drugs other than their ability to lower cholesterol.


'"/>

Contact: Teresa
thagan@bma.org.uk
44-207-383-6174
BMJ Specialty Journals
16-Nov-2005


Page: 1

Related medicine news :

1. Cholesterol-lowering drugs reduce risk of stroke, heart attack
2. Cholesterol in stroke patients exceeds national guidelines
3. Cholesterol-lowering drugs may be useful in an influenza pandemic
4. Cholesterol-lowering drugs not associated with increased breast cancer risk
5. Cholesterol levels discounted as a biological marker for suicide risk among alcoholics
6. Cholesterol levels and use of lipid-lowering drugs are not associated with breast cancer risk
7. Older patients with major depression live longer with appropriate treatment, Penn study shows
8. Boosting key protein in brain could improve seizure treatment, Stanford study finds
9. Cancer researchers confirm brain tumor genetic subtype informs treatment, predicts outcome
10. JRRD tipsheet: Focus on stroke, Parkinsons treatment, wheelchair durability
11. Asymptomatic HIV-infected newborns may benefit from early drug treatment, Stanford study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the ... in an average life. This mouse sets out on a journey that will show ... Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has ...
(Date:9/20/2017)... ... September 20, 2017 , ... Ron Norman, CEO of Team ... week about the value of senior executives, pointed to a quote from William ... has brought us to the present and will lead us into the future," ...
(Date:9/20/2017)... ... 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl ... published author, Jeanine Liston, a busy mother of five who used her time waiting for ... this book for over twenty years. It was a way to give some meaning ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her Funeral”: a tale of ... revealing the skeletons in their closets. “They Sang At Her Funeral” is the creation ... young and married with five children and twelve grandchildren. Before becoming a writer, Annalise ...
Breaking Medicine News(10 mins):
(Date:8/28/2017)... Aug. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... Monday, September 11, 2017, in New York ... officer, is scheduled to present at 11:05 a.m. Eastern Time. ... at http://ir.hill-rom.com/events.cfm . A recorded replay will be available ... December 10, 2017. ...
(Date:8/25/2017)... www.innovationzed.com ), an Irish medtech company, today announced that it has commenced ... Bassetlaw, England . The collaboration sees the ... a national NHS Test Bed programme exploring new models of care. ... Innovation Zed ... snap-on accessory for disposable insulin pen users, automatically collects and records pen ...
(Date:8/24/2017)... BioBridges, a Career Portfolio® Management company providing ... to announce its corporate sponsorship of the upcoming fourth ... the event will benefit charitable foundations affiliated with each ... delighted to return once again as a sponsor of ... Jason Falchuk , BioBridges Founding Partner. "Our life ...
Breaking Medicine Technology:
Cached News: